HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoprotein (a): More than a bystander in the etiology of hypertension? A study on essential hypertensive patients not yet on treatment.

AbstractBACKGROUND:
Hypertension (HTN) is a very common disorder with a substantial impact on public health because of its complications.
OBJECTIVES:
To study the association of serum lipoprotein(a) [Lp(a)] elevation with essential hypertension (eHTN).
PATIENTS AND METHODS:
This study was conducted on a group of essential hypertensive patients. Laboratory exams consisting of serum creatinine and Lp(a) were measured.
RESULTS:
Ninety five essential hypertensive patients were enrolled to the study. Serum LP (a) in patients was 46.5±20. In patients an inverse correlation between serum Lp(a) andcreatinine clearance was seen (r = -0.175 p<0.05). There was a significant correlation between serum Lp(a) and age (r =0.191 p<0.05) or duration of HTN (known duration of hypertension period) (r =0.362 p<0.05).
CONCLUSIONS:
Our data suggest that Lp(a) may be involved as a cofactor in essential hypertension, with a mechanism that remains to be elucidated.
AuthorsAli Ghorbani, Mahmoud Rafieian-Kopaei, Hamid Nasri
JournalJournal of nephropathology (J Nephropathol) Vol. 2 Issue 1 Pg. 67-70 (Jan 2013) ISSN: 2251-8363 [Print] Iran
PMID24475427 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: